| Rank |
Title (Publication Date) (Number of Views Online) |
Author(s) |
Department |
| 1 |
Attention-Deficit-Hyperactivity Disorder: An Update (June 2009) (3592) |
Julie A. Dopheide, Pharm.D., and Steven R. Pliszka, M.D. |
TR |
| 2 |
Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis (May 2009) (3289) |
Brett H. Heintz, Pharm.D., Gary R. Matzke, Pharm.D., and William E. Dager, Pharm.D. |
TR |
| 3 |
Antimicrobial Dosing Considerations in Obese Adult Patients: Insights from the Society of Infectious Diseases Pharmacists (August 2007) (2159) |
Manjunath P. Pai, Pharm.D., and David T. Bearden, Pharm.D. |
SA |
| 4 |
Therapeutic Monitoring of Vancomycin in Adults: Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists (November 2009) (1772) |
Michael J. Rybak, Pharm.D., MPH, Ben M. Lomaestro, Pharm.D., John C. Rotschafer, Pharm.D., Robert C. Moellering Jr., M.D., William A. Craig, M.D., Marianne Billeter, Pharm.D., Joseph R. Dalovisio, M.D., and Donald P. Levine, M.D. |
SA |
| 5 |
Treatment of Hepatorenal Syndrome (October 2009) (1766) |
Tyree H. Kiser, Pharm.D., Robert MacLaren, Pharm.D., and Douglas N. Fish, Pharm.D. |
TR |
| 6 |
Agents for the Decolonization of Methicillin-Resistant Staphylococcus aureus (March 2009) (1604) |
Kevin W. McConeghy, Dennis J. Mikolich, M.D., and Kerry L. LaPlante, Pharm.D. |
TR |
| 7 |
Vitamin D and Cardiovascular Disease (June 2009) (1565) |
Carrie W. Nemerovski, Pharm.D., Michael P. Dorsch, Pharm.D., Robert U. Simpson, Ph.D., Henry G. Bone, M.D., Keith D. Aaronson, M.D., and Barry E. Bleske, Pharm.D. |
TR |
| 8 |
Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for Prophylaxis and Treatment of Thromboembolic Diseases (November 2008) (1541) |
Brooke E. Baetz, Pharm.D., and Sarah A. Spinler, Pharm.D. |
TR |
| 9 |
Weight-Based Dosing of Enoxaparin in Obese Patients with Non–ST-Segment Elevation Acute Coronary Syndromes: Results from the CRUSADE Initiative (June 2009) (1515) |
Sarah A. Spinler, Pharm.D., Fang-Shu Ou, M.S., Matthew T. Roe, M.D., MHS, W. Brian Gibler, M.D., E. Magnus Ohman, M.D., Charles V. Pollack, M.D., M.A., Karen P. Alexander, M.D., and Eric D. Peterson, M.D., MPH |
ORA |
| 10 |
Ceftobiprole: First Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (May 2009) (1510) |
Céline Vidaillac, Pharm.D., Ph.D., and Michael J. Rybak, Pharm.D., MPH |
TR |
ORA = original research article; SA = special article; TR = review of therapeutics.